Reducing hip fracture risk with risedronate in elderly women with established osteoporosis

Overview of attention for article published in Clinical Interventions in Aging, November 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

policy: 1 policy source
twitter: 1 X user

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 50 Mendeley

Summary Policy documents X Wikipedia Dimensions citations

So far, Dimensions has found 20 publications that cite this research output.

20

The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.

Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials

Article in The BMJ (May 2023)

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

Article in Cochrane Database of Systematic Reviews (May 2022)

Patient-specific risk factors for adverse outcomes following geriatric proximal femur fractures

Article in European Journal of Trauma and Emergency Surgery (March 2022)